Impact of Genomic Methylation on Radiation Sensitivity of Colorectal Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 5, 2010, Pages 1512-1519

  Hofstetter, Barbara ^a   Niemierko, Andrzej ^b   Forrer, Christian ^a   Benhattar, Jean ^c   Albertini, Veronica ^d   Pruschy, Martn ^a   Bosman, Fred T ^c   Catapano, Carlo V ^d   Ciernik, I Frank ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Colorectal Carcinoma; Demethylation; Epigenomics; Ionizing Radiation; Radiosensitization

Indexed keywords

CELL CYCLE; CELL CYCLING; CELL LINES; CLONOGENIC SURVIVAL; COLORECTAL CARCINOMA; CONFIDENCE INTERVAL; CYTIDINE; DEMETHYLATION; DNA DAMAGE RESPONSE; DOUBLE MUTANTS; HYPOMETHYLATION; INTRINSIC RADIATION; LOW DOSE; PROMOTER METHYLATION; RADIATION SENSITIVITY; RADIO-SENSITIZATION; SENSITIZING EFFECTS; TARGET GENES;

ALKYLATION; CELL CULTURE; CELLS; GENES; IONIZING RADIATION; METHYLATION; RADIATION SHIELDING; RADIOACTIVITY;

RADIATION EFFECTS;

AZACITIDINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; PROTEIN MLH1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEMETHYLATION; DNA DAMAGE; GENE DELETION; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; GENOMICS; HUMAN; HUMAN CELL; IONIZING RADIATION; LOW DRUG DOSE; MUTANT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; RADIOSENSITIVITY; SENSITIVITY AND SPECIFICITY; TUMOR CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AZACITIDINE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE DELETION; HUMANS; NUCLEAR PROTEINS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS;

EID: 77949546881     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.10.037     Document Type: Article

References (43)

1. Oehler C., and Ciernik I.F. Radiation therapy and combined modality treatment of gastrointestinal carcinomas. Cancer Treat Rev 34 (2006) 220-240
2. Teodoridis J.M., Strathdee G., Plumb J.A., et al. CpG-island methylation and epigenetic control of resistance to chemotherapy. Biochem Soc Trans 32 (2004) 916-917
3. Cheng J.C., Matsen C.B., Gonzales F.A., et al. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst 95 (2003) 399-409
4. Dote H., Cerna D., Burgan W.E., et al. Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine. Clin Cancer Res 11 (2005) 4571-4579
5. De Schutter H., Kimpe M., Isebaert S., et al. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 73 (2009) 904-912
6. Flotho C., Claus R., Batz C., et al. The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia 23 (2009) 1019-1028
7. Esteller M., Fraga M.F., Guo M., et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 10 (2001) 3001-3007
8. Momparler R.L., and Bovenzi V. DNA methylation and cancer. J Cell Physiol 183 (2000) 145-154
9. Robertson K.D., and Jones P.A. DNA methylation: Past, present and future directions. Carcinogenesis 21 (2000) 461-467
10. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349 (2003) 2042-2054
11. Shannon B.A., and Iacopetta B.J. Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma: Associations with clinicopathological features. Cancer Lett 167 (2001) 91-97
12. Belinsky S.A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4 (2004) 707-717
13. Bender C.M., Pao M.M., and Jones P.A. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 58 (1998) 95-101
14. Stone R.M. How I treat patients with myelodysplastic syndromes. Blood 113 (2009) 6296-6303
15. Gius D., Cui H., Bradbury C.M., et al. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 6 (2004) 361-371
16. Rhee I., Bachman K.E., Park B.H., et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416 (2002) 552-556
17. Esteller M., Corn P.G., Baylin S.B., et al. A gene hypermethylation profile of human cancer. Cancer Res 61 (2001) 3225-3229
18. Suzuki H., Gabrielson E., Chen W., et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31 (2002) 141-149
19. Gerweck L.E., Dullea R., Zaidi S.T., et al. Influence of experimental factors on intrinsic radiosensitivity assays at low doses of radiation: Cell multiplicity. Radiat Res 138 (1994) 361-366
20. Clement G., and Benhattar J. A methylation sensitive dot blot assay (MS-DBA) for the quantitative analysis of DNA methylation in clinical samples. J Clin Pathol 58 (2005) 155-158
21. Clement G., Braunschweig R., Pasquier N., et al. Methylation of APC, TIMP3, and TERT: A new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation. J Pathol 208 (2006) 100-107
22. Toyota M., Ahuja N., Ohe-Toyota M., et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96 (1999) 8681-8686
23. Ahuja N., Mohan A.L., Li Q., et al. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 57 (1997) 3370-3374
24. Kawabe S., Roth J.A., Wilson D.R., et al. Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner. Oncogene 19 (2000) 5359-5366
25. Fu X.Y., Zhang S.W., Ran R.Q., et al. Restoration of the p16 gene is related to increased radiosensitivity of p16-deficient lung adenocarcinoma cell lines. J Cancer Res Clin Oncol 124 (1998) 621-626
26. Fritzell J.A., Narayanan L., Baker S.M., et al. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation. Cancer Res 57 (1997) 5143-5147
27. Davis T.W., Wilson-Van Patten C., Meyers M., et al. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res 58 (1998) 767-778
28. Caldwell G.M., Jones C., Gensberg K., et al. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 64 (2004) 883-888
29. Teodoridis J.M., Hall J., Marsh S., et al. CpG island methylation of DNA damage response genes in advanced ovarian cancer. Cancer Res 65 (2005) 8961-8967
30. Veeck J., Niederacher D., An H., et al. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene (2006)
31. Brueckl W.M., Grombach J., Wein A., et al. Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI). Cancer Lett 223 (2005) 137-142
32. Albright N. Computer programs for the analysis of cellular survival data. Radiat Res 112 (1987) 331-340
33. Ghoshal K., and Bai S. DNA methyltansferases as targets for cancer therapy. Drugs Today (Barc) 43 (2007) 395-422
34. Karam J.A., Fan J., Stanfield J., et al. The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agen 5-azacytidine in human bladder cancer therapy. Int J Cancer 120 (2007) 1795-1802
35. Ying J., Srivastava G., Hsieh W.S., et al. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res 11 (2005) 6442-6449
36. Fratelli M., Goodwin L.O., Orom U.A., et al. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc Natl Acad Sci U S A 102 (2005) 13998-14003
37. Pantoja C., de Los Rios L., Matheu A., et al. Inactivation of imprinted genes induced by cellular stress and tumorigenesis. Cancer Res 65 (2005) 26-33
38. Koturbash I., Baker M., Loree J., et al. Epigenetic dysregulation underlies radiation-induced transgenerational genome instability in vivo. Int J Radiat Oncol Biol Phys 66 (2006) 327-330
39. Meechan P.J., Haraf D.J., Diamond A.M., et al. Reversion of radiosensitivity in azacytidine-treated XRS5 cells does not result in full radioprotection by WR-1065. Int J Radiat Oncol Biol Phys 23 (1992) 999-1002
40. Kim W.J., Vo Q.N., Shrivastav M., et al. Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line. Oncogene 21 (2002) 3864-3871
41. Chen R.Z., Pettersson U., Beard C., et al. DNA hypomethylation leads to elevated mutation rates. Nature 395 (1998) 89-93
42. Gaudet F., Hodgson J.G., Eden A., et al. Induction of tumors in mice by genomic hypomethylation. Science 300 (2003) 489-492
43. Chan A.T., Tao Q., Robertson K.D., et al. Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors. J Clin Oncol 22 (2004) 1373-1381